Welcure Drugs & Pharmaceuticals Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 736142,
    "name": "Welcure Drugs",
    "stock_name": "Welcure Drugs",
    "full_name": "Welcure Drugs & Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/welcure-drugs",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "0.30",
    "chg": 0.01,
    "chgp": "3.45%",
    "dir": 1,
    "prev_price": "0.29",
    "mcapval": "37.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524661,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE331C01025",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "1.37 cr",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/welcure-drugs-736142-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Welcure Drugs & Pharmaceuticals Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/welcure-drugs-pharmaceuticals-faces-intense-selling-pressure-amid-lower-circuit-3746824",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/WelcureDrugsPha_only_sellers_3746824.png",
        "date": "2025-12-04 13:25:47",
        "description": "Welcure Drugs & Pharmaceuticals Ltd has encountered significant selling pressure, with the stock registering a sharp decline and exhibiting a complete absence of buying interest. The pharmaceutical company’s shares have fallen for two consecutive sessions, reflecting distress selling signals and a challenging market environment."
      },
      {
        "title": "Welcure Drugs & Pharmaceuticals Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/welcure-drugs-pharmaceuticals-faces-severe-selling-pressure-hits-lower-circuit-amid-distress-signals-3744247",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/WelcureDrugsPha_only_sellers_3744247.png",
        "date": "2025-12-03 12:00:38",
        "description": "Welcure Drugs & Pharmaceuticals Ltd is currently experiencing significant selling pressure, with the stock registering a sharp decline and only sell orders visible in the market queue. This distress selling signals a challenging phase for the company amid broader market fluctuations."
      },
      {
        "title": "Welcure Drugs & Pharmaceuticals Surges with Unprecedented Buying Interest",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/welcure-drugs-pharmaceuticals-hits-upper-circuit-amidst-unprecedented-buying-frenzy-3740993",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/WelcureDrugsPha_only_buyers_3740993.png",
        "date": "2025-12-02 09:36:02",
        "description": "Welcure Drugs & Pharmaceuticals has captured market attention with an extraordinary surge in buying activity, registering a 3.64% gain today while the broader Sensex declined by 0.25%. The stock’s unique position of having only buy orders in the queue signals a potential multi-day upper circuit scenario, reflecting robust investor enthusiasm amid a challenging market backdrop."
      },
      {
        "title": "Welcure Drugs & Pharmaceuticals Hits Upper Circuit Amidst Unprecedented Buying Interest",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/welcure-drugs-pharmaceuticals-hits-upper-circuit-amidst-unprecedented-buying-interest-3738526",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/WelcureDrugsPha_only_buyers_3738526.png",
        "date": "2025-12-01 11:25:41",
        "description": "Welcure Drugs & Pharmaceuticals Ltd has witnessed extraordinary buying momentum today, with the stock hitting its upper circuit and registering only buy orders in the queue. This rare market phenomenon highlights intense demand and a complete absence of sellers, signalling a potential multi-day circuit scenario for the pharmaceutical company."
      },
      {
        "title": "Welcure Drugs & Pharmaceuticals Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/welcure-drugs-pharmaceuticals-faces-severe-selling-pressure-amid-lower-circuit-3724277",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/WelcureDrugsPha_only_sellers_3724277.png",
        "date": "2025-11-24 09:50:32",
        "description": "Welcure Drugs & Pharmaceuticals Ltd has encountered significant selling pressure, with the stock registering a sharp decline and exhibiting a complete absence of buyers on the trading day. This distress selling signals a challenging phase for the company amid a broader market environment where the Sensex remains steady."
      },
      {
        "title": "Why is Welcure Drugs falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-welcure-drugs-fallingrising-3722089",
        "imagepath": "",
        "date": "2025-11-22 01:01:19",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>Welcure Drugs’ recent price action reflects a brief respite in an otherwise challenging year for the stock. While it gained 3.57% on 21-Nov, the stock remains significantly down over multiple time frames. Year-to-date, the share price has declined by 44.78%, contrasting sharply with the Sensex’s 9.08% gain over the same period. Over the past year, Welcure Drugs has fallen 20.14%, whereas the Sensex advanced 10.47%. Even on a three-year horizon, the stock lags the benchmark, down 6.33% compared to the Sensex’s robust 39.39% rise.</p>\n<p>This disparity highlights the stock’s persistent underperformance despite sporadic rallies. However, the five-year return tells a different story, with Welcure Drugs delivering an impressive 228.80% gain..."
      },
      {
        "title": "Welcure Drugs & Pharmaceuticals Hits Upper Circuit Amidst Unprecedented Buying Interest",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/welcure-drugs-pharmaceuticals-hits-upper-circuit-amid-unprecedented-buying-interest-3720098",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/WelcureDrugsPha_only_buyers_3720098.png",
        "date": "2025-11-21 09:40:57",
        "description": "Welcure Drugs & Pharmaceuticals Ltd has witnessed extraordinary buying momentum, hitting the upper circuit with only buy orders in the queue. This rare market phenomenon highlights intense demand and the absence of sellers, signalling a potential multi-day circuit scenario for the pharmaceutical company’s stock."
      },
      {
        "title": "Welcure Drugs & Pharmaceuticals Hits Upper Circuit Amidst Unprecedented Buying Interest",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/welcure-drugs-pharmaceuticals-hits-upper-circuit-amidst-unprecedented-buying-interest-3717360",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/WelcureDrugsPha_only_buyers_3717360.png",
        "date": "2025-11-20 09:41:06",
        "description": "Welcure Drugs & Pharmaceuticals Ltd has witnessed extraordinary buying momentum today, with the stock hitting its upper circuit and registering only buy orders in the queue. This rare market phenomenon highlights intense demand and a complete absence of sellers, signalling a potential multi-day circuit scenario for the microcap pharmaceutical player."
      },
      {
        "title": "Why is Welcure Drugs falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-welcure-drugs-fallingrising-3716316",
        "imagepath": "",
        "date": "2025-11-19 22:59:44",
        "description": "As of 19-Nov, Welcure Drugs & Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at 0.54, with a change of -0.02, representing a decrease of 3.57%. The stock has been underperforming significantly, having lost 15.63% over the last four days and showing a substantial decline of 27.03% over the past month. Additionally, it is trading below all key moving averages, indicating a bearish trend. The delivery volume has also decreased sharply, falling by 65.33% compared to the five-day average, which suggests a lack of investor interest. Unfortunately, there are no positive or negative factors provided to further explain the stock's recent movement.\n\nIn the broader market context, Welcure Drugs has underperformed relative to the Sensex, which has gained 0.85% over the past week while the stock has dropped 11.48%. Year-to-date, the stock has fallen by 48.59%, contrasting sharply with the Se..."
      }
    ],
    "total": 253,
    "sid": "736142",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/welcure-drugs-pharmaceuticals-736142"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "05-Jan-2026",
      "details": "Certificate under Regulation 74 (5) of SEBI (DP) Regulations 2018 for the 3rd Quarter ended 31st December 2025.",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "24-Dec-2025",
      "details": "Intimation of Closure of Trading Window",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of Welcure Drugs And Pharmaceuticals Limited Held Today I.E. Saturday December 06 2025",
      "datetime": "06-Dec-2025",
      "details": "Outcome of the Meeting of the Board of Directors of Welcure Drugs and Pharmaceuticals Limited held today i.e. Saturday December 06 2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Welcure Drugs & Pharmaceuticals Ltd has announced <strong>1:10</strong> stock split, ex-date: 16 Oct 25",
          "dt": "2025-10-16",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Welcure Drugs & Pharmaceuticals Ltd has announced <strong>1:10</strong> bonus issue, ex-date: 16 Oct 25",
          "dt": "2025-10-16",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Welcure Drugs & Pharmaceuticals Faces Intense Selling Pressure Amid Consecutive Losses

2025-12-04 13:25:47

Welcure Drugs & Pharmaceuticals Ltd has encountered significant selling pressure, with the stock registering a sharp decline and exhibiting a complete absence of buying interest. The pharmaceutical company’s shares have fallen for two consecutive sessions, reflecting distress selling signals and a challenging market environment.

Welcure Drugs & Pharmaceuticals Faces Intense Selling Pressure Amid Consecutive Losses

2025-12-03 12:00:38

Welcure Drugs & Pharmaceuticals Ltd is currently experiencing significant selling pressure, with the stock registering a sharp decline and only sell orders visible in the market queue. This distress selling signals a challenging phase for the company amid broader market fluctuations.

Welcure Drugs & Pharmaceuticals Surges with Unprecedented Buying Interest

2025-12-02 09:36:02

Welcure Drugs & Pharmaceuticals has captured market attention with an extraordinary surge in buying activity, registering a 3.64% gain today while the broader Sensex declined by 0.25%. The stock’s unique position of having only buy orders in the queue signals a potential multi-day upper circuit scenario, reflecting robust investor enthusiasm amid a challenging market backdrop.

Welcure Drugs & Pharmaceuticals Hits Upper Circuit Amidst Unprecedented Buying Interest

2025-12-01 11:25:41

Welcure Drugs & Pharmaceuticals Ltd has witnessed extraordinary buying momentum today, with the stock hitting its upper circuit and registering only buy orders in the queue. This rare market phenomenon highlights intense demand and a complete absence of sellers, signalling a potential multi-day circuit scenario for the pharmaceutical company.

Welcure Drugs & Pharmaceuticals Faces Intense Selling Pressure Amid Consecutive Losses

2025-11-24 09:50:32

Welcure Drugs & Pharmaceuticals Ltd has encountered significant selling pressure, with the stock registering a sharp decline and exhibiting a complete absence of buyers on the trading day. This distress selling signals a challenging phase for the company amid a broader market environment where the Sensex remains steady.

Why is Welcure Drugs falling/rising?

2025-11-22 01:01:19

Recent Price Movement and Market Context Welcure Drugs’ recent price action reflects a brief respite in an otherwise challenging year for the stock. While it gained 3.57% on 21-Nov, the stock remains significantly down over multiple time frames. Year-to-date, the share price has declined by 44.78%, contrasting sharply with the Sensex’s 9.08% gain over the same period. Over the past year, Welcure Drugs has fallen 20.14%, whereas the Sensex advanced 10.47%. Even on a three-year horizon, the stock lags the benchmark, down 6.33% compared to the Sensex’s robust 39.39% rise. This disparity highlights the stock’s persistent underperformance despite sporadic rallies. However, the five-year return tells a different story, with Welcure Drugs delivering an impressive 228.80% gain...

Welcure Drugs & Pharmaceuticals Hits Upper Circuit Amidst Unprecedented Buying Interest

2025-11-21 09:40:57

Welcure Drugs & Pharmaceuticals Ltd has witnessed extraordinary buying momentum, hitting the upper circuit with only buy orders in the queue. This rare market phenomenon highlights intense demand and the absence of sellers, signalling a potential multi-day circuit scenario for the pharmaceutical company’s stock.

Welcure Drugs & Pharmaceuticals Hits Upper Circuit Amidst Unprecedented Buying Interest

2025-11-20 09:41:06

Why is Welcure Drugs falling/rising?

2025-11-19 22:59:44

As of 19-Nov, Welcure Drugs & Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at 0.54, with a change of -0.02, representing a decrease of 3.57%. The stock has been underperforming significantly, having lost 15.63% over the last four days and showing a substantial decline of 27.03% over the past month. Additionally, it is trading below all key moving averages, indicating a bearish trend. The delivery volume has also decreased sharply, falling by 65.33% compared to the five-day average, which suggests a lack of investor interest. Unfortunately, there are no positive or negative factors provided to further explain the stock's recent movement. In the broader market context, Welcure Drugs has underperformed relative to the Sensex, which has gained 0.85% over the past week while the stock has dropped 11.48%. Year-to-date, the stock has fallen by 48.59%, contrasting sharply with the Se...

View All News